BiochemAg97In reply to Player To Be Named Later • 3:55p, 5/4/20AG
Player To Be Named Later said:
Is your office starting to do anti-body testing? If so, which test are y’all running with?
Thanks for all you do!I’m not that kind of Doctor. PhD not MD.
The company I work for is involved in almost every aspect of the response to this disease, from the early structural work and genetic sequencing, to rtPCR tests, to production of PPE and some of the drugs, to vaccine development, and likely vaccine production when we get there.
We don’t currently produce an antibody test. That has repeatedly been answered as we will only put our brand behind a quality antibody test, but we will help scale manufacturing if/when we find the right partner.
As for which antibody test I would recommend... stick with the tests that have EUA from the FDA.
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations#covid19ivd
Some of those only test for IgG which is weeks after exposure but more likely to indicate recovered or near recovered patient. IgM/IgG tests has the ability to detect earlier in the process (IgM shows up before IgG) and could identify someone in the middle of an infection. Not as earlier as a nucleotide test, but if someone is IgM positive and IgG negative, they probably need a PCR test and self quarantine.
ReveilleIn reply to Player To Be Named Later • 6:49p, 5/4/20AG
Player To Be Named Later said:
Running the blood draws or the finger stick test?
We are doing the blood tests. Our IgG test actually has a specificity of 99.5% by Abbott labs
The Roche test is IgG and IgM has a specificity of 99.8% and sensitivity of 100% . However, it is being delayed due to shortage of reagents in the lab.